Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Retirement of Director

On February 16, 2026, Dr. Cynthia M. Friend informed the Board of Directors ("Board") of Bruker Corporation (the "Company") of her decision not to stand for re-election as a Class II director when her current term expires at the Company's 2026 Annual Meeting of Stockholders ("2026 Annual Meeting"). Dr. Friend's decision is not due to any disagreement with the Company on any matter relating to its operations, policies, or practices and she intends to continue to serve as a director for the remainder of her current term. Dr. Friend has served on the Board since May 2016 and currently serves as a member of the Board's Compensation Committee.

On February 19, 2026, Jack Phillips stepped down as a Class III member of the Board and the Board immediately thereafter re-elected him as a Class II director. For all purposes, Mr. Phillips' service on the Board is deemed to have continued, uninterrupted and unchanged (including with respect to compensation and benefits), since January 1, 2026, the date that Mr. Phillips first joined the Board. As a newly appointed Class II director, Mr. Phillips will stand for re-election at the 2026 Annual Meeting.

Section 8 - Other Events

Item 8.01. Other Events.

The Board of Directors of Bruker Corporation declared a quarterly cash dividend on the Company's common stock, $0.01 par value per share, of $0.05 per share. The dividend was declared on February 19, 2026, and is payable April 7, 2026, to shareholders of record at the close of business on March 23, 2026.